BusinessCRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer TherapiesBy Nasdaq OMXAug 22, 2017, 11:30 AM UTC
BusinessOmniSeq and LabCorp Sign Exclusive Distribution Agreement and Series B Funding CommitmentBy Nasdaq OMXAug 21, 2017, 12:01 PM UTC
BusinessaTyr Pharma Announces Second Quarter 2017 Operating Results and Provides an Update on Innovative Immunology PipelineBy Nasdaq OMXAug 14, 2017, 8:06 PM UTC
BusinessCrown Bioscience Announces Second Quarter Results, Appoints Dr. Yangzhou Wang as Sr. VP of Global OperationsBy Nasdaq OMXAug 14, 2017, 4:00 AM UTC
BusinessLentigen Technology Inc., a Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma, Inc.By Nasdaq OMXJul 20, 2017, 12:00 PM UTC
BusinessFluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical ResearchBy Nasdaq OMXJul 18, 2017, 1:01 PM UTC
BusinessPeregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2017 and Recent DevelopmentsBy Nasdaq OMXJul 14, 2017, 8:13 PM UTC
BusinessHemispherx Updates Status of Immuno-Oncology Program in Pancreatic CancerBy Nasdaq OMXJul 10, 2017, 12:30 PM UTC
